Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin for COVID-19-associated Coagulopathy
NCT04360824Phase 4Completed
- Sponsor
- University of Iowa
- Start
- May 2020
- Primary completion
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in coagulopathy, sponsored by University of Iowa. Started May 2020; status: completed.
02
Drugs
enoxaparin
03
Conditions
coagulopathy
Beyond the preview
Go deeper on NCT04360824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04360824.